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Abstract
Background: Patient’s knowledge on diabetes, hypertension and hyperlipidaemia and its medications can be used
as one of the outcome measures to assess the effectiveness of educational intervention. To date, no such
instrument has been validated in Malaysia. Therefore, the aim of this study was to evaluate the validity and
reliability of the Diabetes, Hypertension and Hyperlipidemia (DHL) knowledge instrument for assessing the
knowledge of patients with type 2 diabetes in Malaysia.
Methods: A 28-item instrument which comprised of 5 domains: diabetes, hypertension, hyperlipidemia,
medications and general issues was designed and tested. One point was given for every correct answer, whilst
zero was given for incorrect answers. Scores ranged from 0 to 28, which were then converted into percentage.
This was administered to 77 patients with type 2 diabetes in a tertiary hospital, who were on medication(s) for
diabetes and who could understand English (patient group), and to 40 pharmacists (professional group). The DHL
knowledge instrument was administered again to the patient group after one month. Excluded were patients less
than 18 years old.
Results: Flesch reading ease was 60, which is satisfactory, while the mean difficulty factor(SD) was 0.74(0.21),
indicating that DHL knowledge instrument was moderately easy. Internal consistency of the instrument was good,
with Cronbach’s a = 0.791. The test-retest scores showed no significant difference for 26 out of the 28 items,
indicating that the questionnaire has achieved stable reliability. The overall mean(SD) knowledge scores was
significantly different between the patient and professional groups [74.35(14.88) versus 93.84(6.47), p < 0.001]. This
means that the DHL knowledge instrument could differentiate the knowledge levels of participants. The DHL
knowledge instrument shows similar psychometric properties as other validated questionnaires.
Conclusions: The DHL knowledge instrument shows good promise to be adopted as an instrument for assessing
diabetic patients’ knowledge concerning their disease conditions and medications in Malaysia.
Keywords: Validation, Diabetes, Knowledge instrument, Malaysia
Background
Diabetes and its complications pose a major health-care
burden worldwide and present major challenges to
patients, health-care systems, and national economies.
The World Health Organization estimates that between
2000 and 2030, the world population will increase by
37% and the number of people with diabetes will
increase by 114% [1]. Asia will be the major site of a
rapidly emerging diabetes epidemic based on population
growth, an increase in the elderly population (> 65 years
of age), and the rate of urbanisation [1]. India and
China will remain the two countries with the highest
numbers of people with diabetes (79·4 million and 42·3
million, respectively) by 2030 [1]. In Malaysia, the preva-
lence of diabetes has escalated from 6.3% in 1986, to
8.3% in 1996, and to 14.9% in 2006 [2]. One in six
Malaysians above the age of 30 years old has diabetes
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[2]. The dramatic increase in the prevalence of diabetes
may be due primarily to the rise in obesity in Malaysia
during the past decade, which has been found to be
associated with rapid urbanization [2,3].
Research has shown that the provision of diabetes
education by healthcare professionals on medications,
diet, exercise, home glucose monitoring, foot care, and
treatment modifications have improved clinical out-
comes and the quality of life of patients [4-6]. Although
knowledge alone does not guarantee a change in beha-
viour or lead to effective self-management [7], the
assessment of diabetes-related knowledge is an impor-
tant step towards providing individualize diabetes educa-
tion programs and to evaluate the effectiveness of such
interventions [8].
A literature search revealed that several instruments
for assessing diabetes knowledge have been developed:
the Michigan Diabetes Knowledge Tool (MDKT) [9],
the Diabetic Knowledge Questionnaire (DKQ) [10,11],
the Diabetes Knowledge Assessment (DKN) scale [12],
the Revised Diabetes Knowledge Scale [13], the Ped-
CarbQuiz (PCQ) [14] and the Diabetic Numeracy Test
(DNT) [15]. Most of these instruments were developed
and validated in the United States [9-11,14,15], whilst
others were developed and validated in Australia [12]
and the United Kingdom [13]. The earliest instrument,
the MDKT was developed and validated in the 1970s
[16]. Most of these instruments were developed in the
English Language [9-11,14,15]. However, several instru-
ments have since been translated to other languages
such as Spanish [10,11], Portuguese [17] and Bahasa
Malaysia [18,19].
These instruments varied widely in their assessment
objectives. The MDKT assessed knowledge on general
issues and insulin use [9], the DKQ assessed general dia-
betes knowledge [10,11], the PCQ assessed carbohydrate
food recognition, carbohydrate food counting and the
incorporation of carbohydrate counting in calculating
insulin dose [14], whilst the DNT measured numeracy
skills for diabetes (food label interpretation, calculation
of insulin dose based on blood, glucose and carbohy-
drate corrections) [15].
The population in which these instruments were
assessed varied between studies. Instruments were vali-
dated in adults with type 1 or type 2 diabetes [9,15], in
adults with type 2 diabetes only [10,11], or in adoles-
cents or children with type 1 diabetes [14,15].
Patient’s knowledge on diabetes, hypertension and
hyperlipidaemia and its medications can be used as one
of the outcome measures to assess the effectiveness of
educational intervention. In Malaysia, two instruments:
the Orang Asli-Diabetes Knowledge Questionnaire (OA-
DKQ) [18] and the MDKT [19] have been translated
into Bahasa Malaysia and validated. The OA-DKQ
assesses diabetes-related knowledge whilst the MDKT
assesses general diabetes knowledge and insulin use.
However to date, no instrument that assesses knowledge
on other cardiovascular metabolic risk factors such as
hypertension and hyperlipidaemia, in addition to dia-
betes knowledge has been developed and validated in
Malaysia. Therefore, the aim of this study was to
develop and validate a comprehensive questionnaire to
assess patient’s knowledge on diabetes, medications, and
other cardiovascular metabolic risk factors which
included hypertension and hyperlipidaemia, for use by
Malaysians with type 2 diabetes mellitus.
Methods
Development of the Diabetes, Hypertension and
Hyperlipidemia (DHL) knowledge instrument
The DHL knowledge instrument was developed for the
community-based Cardiovascular Risk Factors Interven-
tion Strategies (CORFIS) trial. The aim of this trial was
to assess the efficacy of a chronic disease management
strategy in the management of patients with diabetes
and/or hypertension and/or hyperlipidaemia in Malaysia.
This knowledge instrument was then used to measure
the levels of diabetes-related knowledge of participants
in the CORFIS trial. The face and content validity of the
DHL knowledge instrument was established by a group
of 12 experienced pharmacists and researchers, who
went through three drafts of the instrument before pro-
ducing the final version. The final draft was then piloted
on 20 practising community and hospital pharmacists as
well as on five diabetic patients in a tertiary hospital, to
obtain their feedback concerning the clarity and rele-
vance of the instrument. The DHL knowledge instru-
ment was developed in the English Language as English
is understood by a majority of Malaysians. It consists of
28 questions and 5 domains, with each item having true,
false and don’t know options. The 5 domains are: dia-
betes (5 items), hypertension (5 items), hyperlipidemia
(5 items), medications (8 items) and general issues (5
items).
Patient Group
Patients with type 2 diabetes, currently on medications
for their diabetes and who could communicate in Eng-
lish were included in the study. Excluded were children
(< 18 years of age) and those who were not taking any
medication for diabetes. Patients answered the DHL
knowledge instrument twice: at baseline and 4 weeks
later.
Professional Group
To obtain a more objective assessment on the validity of
the DHL knowledge instrument, pharmacists were
recruited (from a tertiary hospital) as the professional
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group. Pharmacists were expected to have higher knowl-
edge of diabetes than patients. The pharmacists
answered the DHL knowledge instrument once only.
Procedure
Patients were recruited from the diabetes clinic of a ter-
tiary hospital in Kuala Lumpur, Malaysia. Baseline infor-
mation such as demographic data, medical history, life
style and medication history were collected. The ques-
tionnaire was administered whilst the patient was wait-
ing to see the doctor. Patients completed the
questionnaire themselves, after instructions were given
by the researcher. Participants took about 10-15 minutes
to complete the DHL knowledge instrument. The com-
pleted questionnaire was checked by the researcher to
ensure that all questions had been answered. The DHL
knowledge instrument was administered again to the
same group of patients after one month, during their
follow up visit at the clinic. Patients were questioned on
any significant changes or events that had occurred
within the one month interval and all changes were
documented. This study was approved by the Medical
Ethics Committee of the hospital under study.
Statistical analyses
All data were entered and analyzed using the Statistical
Package for Social Sciences (SPSS) version 15. The
answers for each question in the knowledge question-
naire was scored as true, false or don’t know. Analyses
was performed by scoring 1 for a correct response and
0 for an incorrect or don’t know response. The total
score was converted into percentage, ranging from 0 to
100 percent. Each domain score was also analyzed by
summing the scores of correct answers and converted
into a scale of 0 to 100. Zero indicates the lowest level
of knowledge, whilst 100 indicates the highest level.
Analysis of the individual (dichotomous) items
The McNemar’s test
This test was used to examine the test-retest reliability
on the individual items.
Flesch reading ease The Flesch reading index is a tool
for estimating the reading comprehension level neces-
sary to understand a written document based on the
average number of syllables per word and the average
number of words per sentence. Scores range from 0 to
100 indicates the level of difficulty in understanding the
document, with lower numbers indicating greater diffi-
culty. An average document should have a score of 60-
70 [20].
Difficulty factor The difficulty factor is defined by the
proportion of patients selecting the right answer to that
question and is calculated by the number of correct
response divided by the total number of responses. It is
a measure of how difficult the question was. The higher
the difficulty factor, the easier the question is. A value
of higher than 0.75 is deemed to be poor as the question
may be too easy. Items with difficulty values between 0.3
and 0.7 are most effective. The optimal level should be
0.5 [21].
Cronbach’s a The internal consistency of the DHL
knowledge instrument was assessed using Cronbach’s a
coefficient. Cronbach’s a value ≥ 0.70 is considered as
having good internal consistency. If omitting an item
increases Cronbach’s a significantly, then excluding the
item will increase the homogeneity of the scale [22].
Analysis of the different domain scores The mean
knowledge score [standard deviation (SD)] was calcu-
lated for each domain. This score reflects the level of
knowledge of each domain. Since the data obtained
were not normally distributed, non-parametric tests
were used.
The Wilcoxon Signed-rank test was used to compare
if there was any significant difference between the test
and retest results. The Mann-Whitney U test was used
to compare if there was any significant difference
between the patient and the professional group.
Spearman’s rho was used to determine correlation
coefficient of the domain scores of the patient group at
test-retest.
Factors associated with knowledge scores Spearman’s
rho and Chi square tests were used to determine if
there were any relationship between demographic fac-
tors and knowledge scores for continuous and categori-
cal variables, respectively. A p value of < 0.05 was
considered as statistically significant.
Results
A total of 117 participants were recruited: 77 (65.8%)
patients and 40 (34.2%) pharmacists (professionals). Of
the 77 patients, 37 (48.1%) were female. Sixteen patients
(15.5%) were excluded in the test-retest analysis as they
did not come for the second follow-up visit even after
being reminded through telephone calls, leaving a total
of 61 patients. Demographic characteristics of patients
are as shown in Table 1.
Psychometric properties of the DHL knowledge
instrument
Flesch reading ease was 60, which was considered as
satisfactory. Internal consistency for the overall DHL
instrument was excellent (Cronbach’s a = 0.791).
Corrected item-total correlations were first used to
identify items which did not agree well with the other
items. Item-total correlations should exceed 0.2 to be
considered as acceptable [1]. Using this criterion, items
5, 7, 9, 17, 19 and 28 did not meet this requirement
(Table 2). The Cronbach’s a value for each item that
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represented the effect of removing that item from the
calculation of the overall Cronbach’s a value was also
computed. The results showed that the internal consis-
tency of the DHL knowledge instrument remained close
to the overall Cronbach’s a of 0.791 with the removal of
any of these items. Therefore, all 28 items were retained.
The difficulty factor for most of the items was satisfac-
tory (0.14-0.92) with a mean(SD) of 0.74(0.21). Out of
28 questions, 8 had a difficulty factor of less than 0.75.
This indicates that the knowledge instrument was mod-
erately easy.
Test-retest reliability was assessed in 61 patients after
a 4-week interval and all domains showed high correla-
tion coefficients (0.391-0.559, p < 0.001). Out of 28
items, only two items (items no. 15 and 19) were found
to be significantly different (Table 2). There was also no
difference between the test-retest scores for all domains
and the overall score (exceptions were the domains on
hypertension and hyperlipidaemia) (Table 3).This
indicates that the DHL knowledge instrument has
achieved stable reliability.
Baseline diabetes-related knowledge levels of patients
and professionals
Table 3 shows the baseline knowledge scores for the
patient and the professional group. The mean scores
for diabetes, hypertension, hyperlipidaemia and medi-
cation were significantly lower in the patient group
compared to the professional group, which then
affected the overall mean(SD) knowledge score [74.4
(14.9) versus 93.8(6.5), p < 0.001] (Table 3). Patients
had fairly good knowledge on diabetes and its general
issues, followed by knowledge on medications, hyper-
tension and hyperlipidemia. The higher the education
level of the patient, the better their knowledge score
(Spearman’s rho = 0.377, p = 0.001). Other demo-
graphic factors such as gender, age, BMI, ethnicity,
monthly income, employment status, duration of
Table 1 Patients’ demographic characteristics
No. of patients (n = 77)
Gender [n (%)]
Female 37 (48.1)
Male 40 (51.9)
Mean age ± SD (years) [range] 62.53 ± 10.97 [25-82]
Ethnicity [n (%)]
Malay 11 (14.3)
Chinese 21 (27.3)
Indian 45 (58.4)
Mean BMI ± SD (kg/m2) [range]** 27.17 ± 4.69 [17.7-51.9]
BMI range [n (%)]**
< 18.5 (underweight) 1 (1.4)
18.5-24.9 (normal) 21 (30.0)
25.0-29.9 (overweight) 33 (47.1)
>/= 30 (obese) 15 (21.4)
Level of education
≤ 6 years of education (none or primary) 3(3.9)
12 years of education (secondary) 38 (49.4)
≥ 15 years of education (diploma/tertiary) 36 (46.8)
Monthly income (RM) [n (%)]
None 58 (75.3)
< 1000 2 (2.6)
1000-3000 9 (11.7)
3001-5000 6 (7.8)
5001-10,000 2 (2.6)
Currently employed [n (%)] 19 (24.7)
Mean duration of diabetes ± SD (years) [range] 19.72 ± 9.98 [3-47]
Exercising ≥ 3 times per week [n (%)] 49 (64.5)
SD = standard deviation; BMI = body mass index; RM = ringgit Malaysia
**Data unavailable for 7 patients
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Table 2 The psychometric properties of the DHL instrument
Difficulty
factor
Corrected
Item-total
correlation
Cronbach’s
a if item is
deleted
Test
retest
reliability
Domain Item p-valuet‡
1. Diabetes occurs in people with insufficient or no insulin# 0.81 0.406 0.780 0.508
2. Diabetes can be cured after taking medicines for a period of time 0.79 0.458 0.777 0.791
3. As long as a diabetic person’s fasting blood sugar level in the
person’s fasti morning is in the normal range, he/she can eat
anything for that day
0.88 0.377 0.782 0.453
4. If the blood sugar level is high for long period of time, it may
cause other health problems such as blindness#
0.92 0.340 0.784 1.000
Diabetes 5. Normal fasting blood sugar is between 4 to 6 mmol/L# 0.90 0.128 0.791 0.453
6. There is no problem for our blood pressure to remain high as long
as we do not feel sick
0.73 0.548 0.771 0.125
7. Blood pressure of 140/90 mmHg and above is considered as high# 0.78 0.190 0.790 0.791
8. If not treated, high blood pressure can lead to kidney damage# 0.70 0.378 0.781 0.180
9. We can feel whether our blood pressure is high or not 0.23 0.125 0.794 0.189
Hypertension 10. High blood pressure can be caused by hardened or narrowed
blood vessels due to fatty deposits#
0.78 0.270 0.786 1.000
11. LDL cholesterol is known as “good” cholesterol 0.14 0.209 0.789 1,000
12. High level of “bad” cholesterol blocks blood vessels the risk of a
heart attack#
0.86 0.252 0.787 0.453
Hyperlipidaemia 13. High level of “bad” cholesterol” can also occur in thin people# 0.86 0.381 0.781 1.000
14. Cholesterol is present in some food and also produced in our liver# 0.69 0.267 0.787 0.238
15. Omega-3 supplements can reduce “bad” cholesterol more than the
medicine given by the doctor
0.29 0.377 0.781 0.019*
16. We can stop taking medicine(s) once our blood sugar/blood
pressure is well controlled.
0.81 0.450 0.777 0.109
17. All medicines must be taken after meals only 0.74 0.179 0.791 0.508
18. If someone misses taking his/her medicine, he/she can take double
the amount for the next dose
0.92 0.518 0.779 0.375
19. People with type 1 diabetes cannot depend on tablets or oral type
of medicines to control their blood sugar#
0.42 0.157 0.794 0.011*
20. All medicines for diabetes are the same, so we can share them if
we have diabetes
0.88 0.273 0.786 0.727
21. Medicines for diabetes or high blood pressure can be taken on
alternate days to reduce side effects
0.84 0.383 0.781 1.000
22. Medicine for reducing cholesterol only has to be taken just before
taking any oily or fatty foods
0.83 0.354 0.782 1.000
Medication 23. All medicines must be stored in the refrigerator 0.90 0.396 0.781 0.388
24. Tobacco smoking increases risk of heart diseases# 0.90 0.385 0.782 0.125
25. If you do not take any white sugar, you will not have enough
energy
0.81 0.355 0.782 0.549
26. Vegetable oils do not contain cholesterol, therefore they are safe to
be taken in large amount
0.75 0.311 0.784 1.000
27. 30 minutes of exercise per week is enough to reduce the risk of
getting heart problems
0.78 0.233 0.788 0.424
General Issues 28. Diabetic people can eat as much fruits (such as banana, papaya,
orange, water melon) as they like
0.90 0.065 0.794 0.062
#Statements are true
‡Test-retest reliability on the individual (dichotomous) items was conducted using the McNemar’s test (binomial distribution was used)
*Statistically significant at p < 0.05
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diabetes and exercise, were not associated with knowl-
edge scores.
Comparison of the DHL knowledge instrument with other
validated instruments
The DHL instrument was compared with other vali-
dated instruments for assessing knowledge on diabetes
(Table 4). The psychometric properties of the DHL
knowledge instrument were similar to these other vali-
dated instruments. For example, the Flesch reading ease
(or equivalent) was around 60 and Cronbach’s alpha
value was above 0.7.
Discussion
The DHL developed in this study performed satisfacto-
rily for most of the psychometric components analysed.
Table 3 Knowledge scores of the professional and patient group at test and retest (by domain)
Test Retest Test-retest reliability [A] versus [B] Discriminant
validity
[A] versus [E]
Patients (n =
77)
[A]
Patients
(n = 61)#
[B]
Wilcoxon Signed Rank
test
[C]
Spearman’s
rho
Correlation
Coefficient**
[D]
Professionals (n =
40)
[E]
Mann Whitney U
test
[F]
Domain Mean ± SD Mean ± SD p-value Mean ± SD p-value
Diabetes 85.97 ± 19.21 91.15 ±
15.29
0.318 0.391 95.50 ± 9.59 0.002*
Hypertension 64.41 ± 23.76 63.61 ±
20.50
0.018* 0.490 92.50 ± 9.81 < 0.001*
Hyperlipidaemia 56.62 ± 23.26 85.97 ±
19.21
0.018* 0.460 93.50 ± 11.45 < 0.001*
Medication 79.22 ± 20.14 79.51 ±
17.08
0.359 0.552 97.19 ± 5.29 < 0.001*
General issues 82.60 ± 20.09 81.97 ±
19.90
0.226 0.559 88.50 ± 17.48 0.100
Total knowledge
score
74.35 ± 14.88 78.04 ±
12.09
0.215 0.617 93.84 ± 6.47 < 0.001*
#16 patients were excluded from the test-retest as they did not come for their follow-up visit
*Statistically significant at p < 0.05
**All correlations were statistically significant at p < 0.01
Table 4 Comparison of psychometric properties of the DHL instrument with other validated instruments for assessing
knowledge in diabetic patients
DHL MDKT DKQ24# PCQ DNT
Mean age [range] (years) 62.53
[25-82]
60.00 (community participants) 56.00 (health dept participants) 50.27 [20-79] 13.2 54.2
No. of subjects 77 811 502 75 398
No. of items 28 23 24 78 43
No. of domains 5 2 1@ 7 5
Flesch reading ease (Flesch Kincaid grade level) 60 (6th grade) NR (6) NR
Cronbach’s a or Kuder
Richardson (KR)
0.791 0.710 0.78 0.88 (0.95)
Difficulty factor 0.74 NR 0.57 NR NR
Mean score (%) 74.35 54.02 (general use)
44.44 (insulin use)
57.00 87.00 61.00
DHL = Diabetes, hypertension and hyperlipidaemia knowledge instrument
MDKT = Michigan Diabetic knowledge tool [9]
DKQ60 = 60 item diabetic knowledge questionnaire [11]
DKQ24 = 24 item diabetic knowledge questionnaire [10]
PCQ = PedCarbQuiz [14]
DNT = Diabetic numeracy test [15]. A more clinically useful 15 items DNT is available
#All 60 items of the DKQ were administered at all data collections; only data pertaining to the 24 items were used for analysis
NR = not reported
@Instrument not divided into domains
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The DHL knowledge instrument had a Flesch reading
ease of 60. This is within the preferred range score of
60-70, indicating that this instrument is suitable for the
average adult to read. Other validated instruments like
the DKT [9] and the PCQ [14] were found to have a
6th Flesch Kincaid grade level, which indicates that the
text is expected to be understandable by an average stu-
dent in the 6th grade (usually around ages 11-12 in the
United States of America). The overall Cronbach’s a
was good (0.791).
The difficulty factor for most of the items was satisfac-
tory (0.14-0.92) with a mean(SD) of 0.74(0.21). Out of
28 questions, 8 had a difficulty factor of less than 0.75.
This indicates that the knowledge instrument was easy
for patients to answer, which was further substantiated
by the mean baseline knowledge score of 74.4(14.9)%.
Other studies on the validation of instruments that
assessed diabetes-related knowledge obtained lower
scores which ranged from 44.4-61.0% [9,10,15]. The
only exception was the study by Koontz et al. [14]
which obtained a score of 87.0%. Patients in the present
study showed the highest knowledge on diabetes [86.0
(19.2)%], and least knowledge on hyperlipidemia [56.6
(23.3)%]. This finding is not unusual as not all diabetic
patients have hyperlipidemia or hypertension and hence
they may not have been provided with information on
these conditions. However, these three diseases are
inter-related, and patients should know about the cardi-
ovascular risk factors associated with diabetes.
The reliability of the DHL was excellent as shown by
the test-retest results. Out of 28 items, only 2 items
showed a significant difference in the test-retest results
which affected the domain scores on hypertension and
hyperlipidaemia. Item 15 ("Omega-3 supplements can
reduce “bad” cholesterol more than the medicine given
by the doctor”) showed a significant improvement in the
retest, indicating that patients may have checked the
information after the initial test. As for item 19 ("People
with type 1 diabetes cannot depend on tablets or oral
type of medicines to control their blood sugar”), less
patients answered these statements correctly at retest. A
possible reason is that the patients “guessed” the
answers correctly during the initial test, but could not
remember their previous answer and hence “guessed”
wrongly the second time.
The overall knowledge scores of the DHL instrument
were higher in the professional group (pharmacists)
than in the patient group (93.8% versus 74.4%) as well
as in all domains. Pharmacists are expected to have
higher level of knowledge on diabetes and its related
issues compared to patients. This indicates that the
DHL instrument is a valid instrument that can be used
to differentiate the knowledge levels of diabetes amongst
its participants.
One of the limitations of this study was the small
sample size. It has been recommended that the number
of participants required should be the number of items
(that is, 28 items) multiplied by 5-10. This means that
at least 140 participants are required. In addition, the
DHL knowledge instrument was only evaluated in the
English language but Malaysia is a multi-racial country.
Therefore, results of this study may not be applicable to
patients who cannot read or understand English. Further
studies using the Bahasa Malaysia and Mandarin ver-
sions of the DHL knowledge instrument are required to
enable the results to be more representative of diabetic
patients in Malaysia.
Conclusions
The psychometric analysis showed that the DHL knowl-
edge instrument has a satisfactory difficulty factor and
shows good promise to be adopted as an instrument for
assessing patients’ knowledge about diabetes and its
medications as well as other cardiovascular metabolic
risk factors in Malaysia. The DHL knowledge instru-
ment can be used to identify individuals in need of edu-
cational interventions and to record changes over time
as treatment progresses for each patient in Malaysia.
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